ABBV — AbbVie Inc · P/E 81, rev $16.99B

AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.

Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.

Use this ABBV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ABBV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ABBV SEC filings page. Lician reads the product cache first so this HTML stays unique to AbbVie Inc even when a live quote feed is slow.

AbbVie Inc latest statements (FY2025)

Latest cached year on this hub. Full ABBV income, balance, and cash tables.

  • Revenue$16.62B
  • Net Income$1.82B
  • Total Assets$133.96B
  • Total Debt$65.00B
  • Free Cash Flow$17.82B

ABBV recent filings